A trial tested an enhanced recovery after surgery (ERAS) protocol in patients who underwent ambulatory transurethral resection (TURBT) of bladder cancer.
Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...
We previously reported initial results from a clinical trial testing a strategy in which patients with muscle-invasive bladder cancer (MIBC) achieving a clinical complete response after cystoscopic ...
, Tongji University School of Medicine, Shanghai, China. 2Urologic Cancer Institute, Tongji University School of Medicine, Shanghai, China. , Tongji University School ...
1 Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China 2 The First Clinical Medical College, Zhengzhou University, Zhengzhou, China The final, formatted ...
Bladder cancer is one of the most prevalent malignant tumors of the urinary system worldwide, and its diagnosis and histopathological grading are crucial for clinical decision-making and prognostic ...
Active surveillance is noninferior to BCG induction therapy for invasive relapse-free survival in patients with high-grade T1 bladder cancer with no residual tumor on second TURBT. For patients with ...
A large electronic health record study suggests that difficulty recognizing painless blood in urine may delay diagnosis and worsen long-term survival for bladder cancer patients with color vision ...
To investigate the association between tumor morphology and muscle-invasive bladder cancer (MIBC) in patients with newly diagnosed bladder cancer (BC). This retrospective study included 416 patients ...
Colorblind people might have a unique disadvantage in noticing an early warning sign of certain cancers, a new study suggests. Reading time 3 minutes Having colorblindness could be even more of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results